Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 16.35
(-25.78%)
USD 16.35
(-25.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 132.6 Million NZD | -47.02% |
| 2023 | 250.3 Million NZD | -33.59% |
| 2022 | 376.9 Million NZD | -28.1% |
| 2021 | 524.2 Million NZD | 82.46% |
| 2020 | 287.3 Million NZD | 37.33% |
| 2019 | 209.2 Million AUD | 9.99% |
| 2018 | 190.2 Million AUD | 12.44% |
| 2017 | 169.15 Million AUD | 17.94% |
| 2016 | 143.42 Million AUD | 26.73% |
| 2015 | 113.17 Million AUD | 16.61% |
| 2014 | 97.05 Million AUD | 25.96% |
| 2013 | 77.05 Million AUD | 20.19% |
| 2012 | 64.11 Million AUD | 22.19% |
| 2011 | 52.46 Million AUD | -26.76% |
| 2010 | 71.63 Million AUD | 15.1% |
| 2009 | 62.23 Million AUD | 76.42% |
| 2008 | 35.27 Million AUD | -38.76% |
| 2007 | 57.6 Million AUD | -17.67% |
| 2006 | 69.96 Million AUD | 13.94% |
| 2005 | 61.4 Million AUD | 12.26% |
| 2004 | 54.69 Million AUD | -24.97% |
| 2003 | 72.9 Million AUD | 51.48% |
| 2002 | 48.12 Million AUD | 395.81% |
| 2001 | 9.7 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 12.65 Million NZD | 0.0% |
| 2024 Q2 | 107.3 Million NZD | 100.0% |
| 2024 Q3 | 12.65 Million NZD | -88.21% |
| 2024 FY | 132.6 Million NZD | -47.02% |
| 2024 Q1 | 53.65 Million NZD | -65.25% |
| 2023 Q1 | 47.95 Million NZD | -69.08% |
| 2023 Q2 | 95.9 Million NZD | 100.0% |
| 2023 Q4 | 154.4 Million NZD | 100.0% |
| 2023 FY | 250.3 Million NZD | -33.59% |
| 2023 Q3 | 77.2 Million NZD | -19.5% |
| 2022 Q4 | 155.1 Million NZD | 100.0% |
| 2022 Q1 | 110.9 Million NZD | -62.87% |
| 2022 FY | 376.9 Million NZD | -28.1% |
| 2022 Q2 | 221.8 Million NZD | 100.0% |
| 2022 Q3 | 77.55 Million NZD | -65.04% |
| 2021 Q1 | 112.75 Million NZD | -32.12% |
| 2021 Q3 | 149.35 Million NZD | -33.77% |
| 2021 Q4 | 298.7 Million NZD | 100.0% |
| 2021 FY | 524.2 Million NZD | 82.46% |
| 2021 Q2 | 225.5 Million NZD | 100.0% |
| 2020 Q1 | 60.6 Million NZD | 8.41% |
| 2020 Q4 | 166.1 Million NZD | 100.0% |
| 2020 Q3 | 83.05 Million NZD | -31.48% |
| 2020 FY | 287.3 Million NZD | 37.33% |
| 2020 Q2 | 121.2 Million NZD | 100.0% |
| 2019 FY | 209.2 Million AUD | 9.99% |
| 2019 Q4 | 55.9 Million NZD | 0.0% |
| 2019 Q3 | 55.9 Million NZD | 14.78% |
| 2019 Q2 | 48.7 Million NZD | 0.0% |
| 2019 Q1 | 48.7 Million NZD | -10.56% |
| 2018 Q3 | 54.45 Million NZD | 33.95% |
| 2018 FY | 190.2 Million AUD | 12.44% |
| 2018 Q1 | 40.65 Million NZD | -10.66% |
| 2018 Q2 | 40.65 Million NZD | 0.0% |
| 2018 Q4 | 54.45 Million NZD | 0.0% |
| 2017 Q1 | 39.1 Million NZD | -3.92% |
| 2017 FY | 169.15 Million AUD | 17.94% |
| 2017 Q4 | 45.5 Million NZD | 0.0% |
| 2017 Q3 | 45.5 Million NZD | 16.37% |
| 2017 Q2 | 39.1 Million NZD | 0.0% |
| 2016 Q4 | 40.69 Million NZD | 0.0% |
| 2016 Q3 | 40.69 Million NZD | 31.19% |
| 2016 Q2 | 31.01 Million NZD | 0.0% |
| 2016 Q1 | 31.01 Million NZD | -3.45% |
| 2016 FY | 143.42 Million AUD | 26.73% |
| 2015 Q1 | 24.45 Million NZD | -6.93% |
| 2015 Q3 | 32.12 Million NZD | 31.36% |
| 2015 Q4 | 32.12 Million NZD | 0.0% |
| 2015 FY | 113.17 Million AUD | 16.61% |
| 2015 Q2 | 24.45 Million NZD | 0.0% |
| 2014 Q1 | 22.24 Million NZD | 1.58% |
| 2014 FY | 97.05 Million AUD | 25.96% |
| 2014 Q3 | 26.28 Million NZD | 18.14% |
| 2014 Q2 | 22.24 Million NZD | 0.0% |
| 2014 Q4 | 26.28 Million NZD | 0.0% |
| 2013 Q4 | 21.9 Million NZD | 0.0% |
| 2013 Q3 | 21.9 Million NZD | 0.0% |
| 2013 FY | 77.05 Million AUD | 20.19% |
| 2012 FY | 64.11 Million AUD | 22.19% |
| 2011 FY | 52.46 Million AUD | -26.76% |
| 2010 FY | 71.63 Million AUD | 15.1% |
| 2009 FY | 62.23 Million AUD | 76.42% |
| 2008 FY | 35.27 Million AUD | -38.76% |
| 2007 FY | 57.6 Million AUD | -17.67% |
| 2006 FY | 69.96 Million AUD | 13.94% |
| 2005 FY | 61.4 Million AUD | 12.26% |
| 2004 FY | 54.69 Million AUD | -24.97% |
| 2003 FY | 72.9 Million AUD | 51.48% |
| 2002 FY | 48.12 Million AUD | 395.81% |
| 2001 FY | 9.7 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 14405.858% |
| Ansell Limited | 76.5 Million USD | -73.333% |
| Ansell Limited | 76.5 Million USD | -73.333% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -446.124% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 8233.757% |
| Psykey, Inc. | -1.32 Million USD | 10115.476% |
| ConvaTec Group Plc | 130.3 Million USD | -1.765% |
| ConvaTec Group Plc | 130.3 Million USD | -1.765% |
| Encision Inc. | -691.78 Thousand USD | 19267.86% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 93604.735% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 56678.173% |
| Innovative MedTech Inc. | -7.93 Million USD | 1770.257% |
| LifePoint, Inc. | -15.23 Million USD | 970.559% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 2046.851% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 28074.684% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 48415.516% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 28987.127% |
| SmileDirectClub, Inc. | -86.4 Million USD | 253.465% |
| Sector 10, Inc. | 7036.00 USD | -1884493.519% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 93.376% |
| SheerVision, Inc. | -71.37 Thousand USD | 185876.732% |
| United Health Products, Inc. | -2.62 Million USD | 5154.766% |
| Vasamed, Inc. | -4.88 Million USD | 2812.681% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 5651.678% |
| Yubo International Biotech Limited | -1.2 Million USD | 11106.296% |